Login to Your Account



MGI Pharma Initiates Dosing For Pivotal Irofulven Study


Thursday, February 8, 2001
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription